Your browser doesn't support javascript.
loading
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPß-dependent suppression of EGFR expression.
Derer, Stefanie; Berger, Sven; Schlaeth, Martin; Schneider-Merck, Tanja; Klausz, Katja; Lohse, Stefan; Overdijk, Marije B; Dechant, Michael; Kellner, Christian; Nagelmeier, Iris; Scheel, Andreas H; Lammerts van Bueren, Jeroen J; van de Winkel, Jan G J; Parren, Paul W H I; Peipp, Matthias; Valerius, Thomas.
Affiliation
  • Derer S; Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Christian-Albrechts-University, Kiel, Germany.
Neoplasia ; 14(3): 190-205, 2012 Mar.
Article in En | MEDLINE | ID: mdl-22496619
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Ras Proteins / CCAAT-Enhancer-Binding Protein-beta / ErbB Receptors Type of study: Prognostic_studies Limits: Aged80 Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2012 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Ras Proteins / CCAAT-Enhancer-Binding Protein-beta / ErbB Receptors Type of study: Prognostic_studies Limits: Aged80 Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2012 Document type: Article Affiliation country: Country of publication: